Payments to Acquire Property, Plant, and Equipment of Inhibikase Therapeutics, Inc. from 31 Dec 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Inhibikase Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
  • Inhibikase Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $13,399.
  • Inhibikase Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $0, a 100% decline from 2023.
  • Inhibikase Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $14,238, a 94% decline from 2022.
  • Inhibikase Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $243,255.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Inhibikase Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $13,399 +$13,399 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1

Inhibikase Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 -$14,238 -100% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $14,238 -$229,017 -94% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $243,255 +$243,255 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.